OUR TECHNOLOGY
Our technology combines custom 128-gene panels with real-time expression analysis to deliver early, accurate, and actionable disease diagnosis
Scroll Down to Know More
TARGETED. ACTIONABLE.
DESIGNED FOR EARLY DETECTION.
Our proprietary 128-gene panels are built for one purpose: early, accurate diagnosis. Each gene is hand-selected for its proven link to disease onset, risk, or progression — delivering clear, clinical-grade insight.
KEY APPLICATIONS
Female Cancer Panels:
Detects breast, ovarian, cervical, and endometrial risk markers.
Male Cancer Panels:
Targets early indicators of prostate and testicular cancer.
Pancreatic Cancer:
One of the most difficult to detect. Caught earlier with molecular precision
These panels move beyond broad screening to provide
focused, high-value diagnostics that can guide real intervention
REAL-TIME GENETIC TESTING
FROM RISK TO ACTIVITY. DETECTING WHAT'S HAPPENING NOW.
REAL-TIME GENETIC TESTING
Our custom panels detect active gene expression tied to early disease. Even when patients feel healthy.
Applications include:
AUTISM
Expression patterns linked to early neurodevelopmental
disruption.
HEART DISEASE
Inflammatory gene activity associated with pre-symptomatic cardiac risk.
ALZEIMER'S & DEMENTIAS
Early changes in brain-related gene expression, often years before symptoms.
This real-time insight makes our tests uniquely powerful, combining prediction with precision.
CURRENT PANELS ADDRESS:
Cancers:
Including breast, ovarian, prostate, testicular and pancreatic.
Neurodegenerative disease:
Alzheimer's, Parkinson's, and related dementias.
Chronic & Developmental Conditions:
Heart disease, autism, and more.
